Multiple Myeloma Treatment Strategies with Novel Agents in 2011: A European Perspective

The arrival of the novel agents thalidomide, bortezomib, and lenalidomide has significantly changed our approach to the management of multiple myeloma and, importantly, patient outcomes have improved. These agents have been investigated intensively in different treatment settings, providing us with...

Full description

Saved in:
Bibliographic Details
Main Authors: Ludwig, Heinz, Beksac, Meral, Bladé, Joan, Cavenagh, Jamie, Cavo, Michele, Delforge, Michel, Dimopoulos, Meletios, Drach, Johannes, Einsele, Hermann, Facon, Thierry, Goldschmidt, Hartmut, Harousseau, Jean-Luc, Hess, Urs, Kropff, Martin, Leal da Costa, Fernando, Louw, Vernon, Magen-Nativ, Hila, Mendeleeva, Larisa, Nahi, Hareth, Plesner, Torben, San-Miguel, Jesús, Sonneveld, Pieter, Udvardy, Miklos, Sondergeld, Pia, Palumbo, Antonio
Format: Artigo
Language:Inglês
Published: AlphaMed Press 2011
Subjects:
Academia-Pharma Intersect
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3228121/
https://ncbi.nlm.nih.gov/pubmed/21441574
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2010-0386
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items